| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6420390586325071 2.992885157959284 0.0027635371730956 0.812032673450829 0.203915292592487 25 P35610,O75845,P48449,Q15800,Q15125,O00767,Q9UBM7,Q14739,O95864,P04035,Q15392,Q16850 12 |
| Mitochondrial complex iv assembly 0.800848769674364 2.925212338676904 0.0034422125775945 0.8754045232714829 0.203915292592487 12 P13073,Q9Y2R0,P14406,Q7KZN9 4 |
| Sphingolipid metabolism in senescence 0.7544870070266813 2.6829013464328004 0.0072986517078319 0.9880204227740296 0.227790486688638 12 Q06136,P16278,Q13510,O15269,P04062,Q96G23 6 |
| Sphingolipid metabolism overview 0.8850243097812748 2.5518960506651753 0.0107138478536563 0.9985056728570252 0.227790486688638 7 Q06136,O95470,Q16880,Q13510,Q96G23 5 |
| Sphingolipid metabolism integrated pathway 0.8850243097812748 2.5518960506651753 0.0107138478536563 0.9985056728570252 0.227790486688638 7 Q06136,O95470,Q16880,Q13510,Q96G23 5 |
| Sphingolipid pathway 0.7842297176995416 2.420755297158377 0.0154882993854339 0.999919570993628 0.2460201860906984 9 Q06136,O95470,Q16880,Q13510,P04062,Q96G23 6 |
| Cholesterol biosynthesis with skeletal dysplasias 0.85501290263924 2.420400925130022 0.0155034033424805 0.9999203128369956 0.2460201860906984 7 O75845,Q15125,Q14739,Q16850,Q15392 5 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6626188553480381 2.3695518260222377 0.0178096588801404 0.9999806723964284 0.2689258490901202 15 P50402,O60725,O75844,P55209,P11802,P48729,P42167 7 |
| Oxidation by cytochrome p450 0.8794940801327717 2.2693783864602484 0.0232453253927511 0.9999993232301276 0.2925036778587853 5 Q16850,Q6UW02,O43169 3 |
| Electron transport chain oxphos system in mitochondria 0.4933445335886267 2.256436355017697 0.024043316989099 0.999999586907266 0.2963706828860367 47 O43676,P21912,P56385,P05141,P13073,P14406,O14949,P12235,O75306,P24539,Q7KZN9,Q9UDW1,P00403,P12236,O75964 15 |
| Influence of laminopathies on wnt signaling 0.6839448590520945 2.189029744083715 0.0285946782085277 0.9999999754591864 0.3428754949018099 11 O75844,O60725 2 |
| Proteoglycan biosynthesis 0.9037315772969616 2.138983809570397 0.032436979628974 0.999999997759866 0.3579432978225317 4 Q8NCH0,Q96L58,Q8TB61 3 |
| Glycosaminoglycan degradation 0.8463900437411576 2.1271166429228208 0.0334103927766282 0.9999999987803332 0.3579432978225317 5 P06865,P16278,P54802 3 |
| Ferroptosis 0.5434185280083326 2.0952373049451345 0.0361499025946596 0.999999999780348 0.3579432978225317 23 Q15043,Q9NZ45,P02786,P45880,P09601,Q9Y277,P04035 7 |
| Allograft rejection 0.6678952861385578 2.001371746668757 0.0453523430885212 0.9999999999993312 0.4045245954250218 10 Q9BY49,P08183,P10321,P04439 4 |
| Statin inhibition of cholesterol production 0.8171267252195606 1.9996089743036456 0.0455425041206978 0.9999999999994073 0.4045245954250218 5 P35610,Q8WTV0,Q14534,P04035 4 |
| Glycerophospholipid biosynthetic pathway 0.7373721327584282 1.8851667662307905 0.0594073261883942 1.0 0.4848922299701371 7 Q86UL3,O95674,O15228,Q9HCL2 4 |
| Mitochondrial complex iii assembly 0.6322611386360311 1.808963937895001 0.0704566060249589 1.0 0.5526725979100676 10 P47985,Q6DKK2,Q9BRT2,O14949,Q9UDW1,P08574 6 |
| Ketogenesis and ketolysis 0.7169356456420187 1.774877171530688 0.0759181704081384 1.0 0.5661058632903162 6 P53985,P23786,O43772 3 |
| Endothelin pathways 0.6828965451266965 1.7642807500423925 0.077684723281528 1.0 0.5713933625301786 8 P00403,P42892 2 |
| Alzheimers disease and mirna effects 0.3990784261967943 1.7225841169725695 0.0849637592780188 1.0 0.6109298881419448 89 P28072,P21796,P04350,P45880,P07437,P60900,Q9BVA1,P42345,O14654,P16615,P62191,O43242,P31751,P05067,P28070,P49721,P68371,Q92542,P12235,P25787,O95197,P12236,O15111,Q96GC9,Q96IX5,P05141,Q9NQC3,Q9Y277,P28074,Q9BUF5 30 |
| Nonalcoholic fatty liver disease 0.4286493172998633 1.6523590214873278 0.0984613840065802 1.0 0.6394696337631661 48 O43676,Q9P0J0,P13073,P14406,O14949,O75306,Q9UDW1,P00403,P31751,Q96GC9,Q16611 11 |
| Degradation pathway of sphingolipids including diseases 0.6848399784405328 1.63641384447749 0.1017530036283878 1.0 0.6480760961958386 7 P06865,P16278,P17900 3 |
| Cholesterol biosynthesis pathway 0.5495721506418907 1.6188059476315344 0.1054890220436017 1.0 0.6501568297381171 14 O75845,P48449,Q15800,Q9UBM7,P04035,Q16850 6 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.6788813223175909 1.5946653170228735 0.1107870978133793 1.0 0.6584413597878389 6 P09601 1 |
| Autophagy 0.6755118102759387 1.5785838149154383 0.1144315494628998 1.0 0.664583229572995 6 Q7Z3C6,P54619,P42345 3 |
| Alzheimers disease 0.3823092581233327 1.5347947345235289 0.1248342566059612 1.0 0.6915266522178686 87 P28072,P21796,P04350,P45880,P07437,P60900,Q9BVA1,P42345,O14654,P16615,P62191,O43242,P31751,P05067,P28070,P49721,P68371,Q92542,P12235,P25787,O95197,P12236,O15111,P05141,Q9NQC3,Q9Y277,P28074,Q9BUF5 28 |
| 15q112 copy number variation syndrome 0.704830614805506 1.4965975288678148 0.1344980135233617 1.0 0.7126035102465834 5 Q96RT7,Q7L576,Q06787,Q96CW5 4 |
| Omega9 fatty acid synthesis 0.6560165084967603 1.4851857505621444 0.137494625616573 1.0 0.7142643310488678 6 O00767 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.5184501755269871 1.4236009659355051 0.1545620160836089 1.0 0.7605671522606574 14 Q9BY49,P23786,O43772 3 |
| Vitamin a and carotenoid metabolism 0.6864089482410383 1.4124261740283486 0.1578245141604726 1.0 0.7626080524234037 5 Q8WTV0,Q6NUM9 2 |
| Familial partial lipodystrophy fpld 0.6059022191724643 1.376753026896142 0.1685886181203768 1.0 0.7673726071794661 8 O75844,O60725 2 |
| Target of rapamycin tor signaling 0.6256428583536958 1.350280479951025 0.1769260312914526 1.0 0.7800242547447988 7 Q15382,P42345,P62942,P04035 4 |
| Triacylglyceride synthesis 0.7112837519127495 1.31782754516889 0.1875613847632276 1.0 0.788133727567675 4 O15228,Q9HCL2 2 |
| Adipogenesis 0.4728682089748915 1.2844878751016418 0.1989713033441866 1.0 0.8044260014746984 17 O75844,P43490,Q9NZ45 3 |
| Ccl18 signaling pathway 0.5230682442907907 1.2784339761095789 0.2010964506109593 1.0 0.8044260014746984 11 P00403,P07196,Q96GC9,Q86UE4 4 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.6542589091547704 1.2649188839255263 0.20590040722791 1.0 0.8044260014746984 5 O00767,P04035 2 |
| Metapathway biotransformation phase i and ii 0.4521325627063529 1.2434078334417047 0.2137175851268842 1.0 0.8044260014746984 20 Q7LGA3,P21964,P78417,Q8NCH0,Q99735,Q6UW02,Q16850,P07099 8 |
| Camkk2 pathway 0.5269608482181616 1.2219172298264522 0.2217389290804807 1.0 0.818191249975027 10 P09601,P42345,O76024 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.9156739811912242 1.2102887803515394 0.2261681013613943 1.0 0.8182168462611493 3 Q06136,O95470 2 |
| Zinc homeostasis 0.920087746787845 1.1906068617574992 0.2338079566154896 1.0 0.8182168462611493 2 Q8TAD4 1 |
| Omega3 omega6 fatty acid synthesis 0.6365020006965019 1.1833014094575534 0.2366897144187123 1.0 0.8182168462611493 5 O95864 1 |
| G1 to s cell cycle control 0.4097527643170967 1.172381730944685 0.2410438309168432 1.0 0.8182168462611493 27 O75419,P24941,Q9UBD5,P06400,P25205,Q14566,Q9Y619,Q99640,P06493,P14635,P33991,P35244,P11802,Q07864 14 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.5858089601504995 1.14530433697698 0.2520831100461309 1.0 0.8182168462611493 6 P09601 1 |
| Glycosylation and related congenital defects 0.5117847707934596 1.135896169768745 0.2560000215136766 1.0 0.8182168462611493 10 Q9BV10,Q9BT22,Q2TAA5,Q9Y5P6 4 |
| Insulin signaling in adipocytes normal condition 0.66874579347148 1.132590894917302 0.257386094022547 1.0 0.8182168462611493 4 P31751 1 |
| Insulin signaling in adipocytes diabetic condition 0.66874579347148 1.132590894917302 0.257386094022547 1.0 0.8182168462611493 4 P31751 1 |
| Estrogen receptor pathway 0.6666643099389657 1.1235463904758036 0.2612055098042516 1.0 0.8260111409516647 4 Q9HCL2 1 |
| Neuroinflammation 0.5761056079345985 1.1080878836867225 0.2678238631423042 1.0 0.8294237480231963 7 P00403,P42345 2 |
| Vitamin d metabolism 0.8852664576802532 1.101392641596714 0.2707258066089948 1.0 0.8294237480231963 3 P04062,P38435 2 |
| 1q211 copy number variation syndrome 0.5278843690683698 1.0948383134624664 0.2735874779242562 1.0 0.8303861139007574 9 Q9NPH0,Q16625 2 |
| Progeriaassociated lipodystrophy 0.4949279147150842 1.0403304313791657 0.2981864106002849 1.0 0.8542698789100105 10 O75844 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4924511086666847 1.026300782956502 0.3047498283498802 1.0 0.8552667931515681 10 P07196,Q9NR77,Q15907 3 |
| Urea cycle and related diseases 0.8705734879348215 1.0064078309415958 0.3142194281938466 1.0 0.8705896083902906 2 Q9Y619 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.505266621178405 0.9732033780926216 0.3304522322377958 1.0 0.8884797411819083 9 Q15382,P31751,P42345 3 |
| Inclusion body myositis 0.8614854277655937 0.973079483795429 0.3305137998086711 1.0 0.8884797411819083 2 Q92542 1 |
| Nanomaterial induced apoptosis 0.544418317818801 0.9446209120680128 0.344852446844998 1.0 0.9036607931504628 6 O43464,O95831,Q16611 3 |
| Head and neck squamous cell carcinoma 0.4420302041202713 0.937789382763789 0.3483526584282068 1.0 0.9036607931504628 14 Q15382,P31751,P11802,P42345,P62942 5 |
| Hostpathogen interaction of human coronaviruses autophagy 0.6158793408327783 0.9046032422955272 0.3656756170379864 1.0 0.9269602341218568 4 P42345 1 |
| Sarscov2 and covid19 pathway 0.6117704981197446 0.8871066499993426 0.3750214841229082 1.0 0.9360237329949748 4 Q8WTV0 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.8361015355687982 0.8810703393221255 0.3782797499302317 1.0 0.940250901061152 2 P08183 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.8072239864745556 0.8278007533033721 0.4077833480175723 1.0 0.9509696610139524 3 P42345 1 |
| Nad biosynthetic pathways 0.8017749672753937 0.809195488200809 0.4184027097198395 1.0 0.9612503326893028 3 P43490 1 |
| Tlr4 signaling and tolerance 0.5536568858683397 0.8061625103512875 0.420149152036384 1.0 0.9612503326893028 5 Q15629,O15111 2 |
| Vitamin dsensitive calcium signaling in depression 0.5069316355976214 0.7653030275510398 0.4440911216496914 1.0 0.994477810503806 6 Q8NB78,P20020 2 |
| Caloric restriction and aging 0.7800026582145619 0.7357672019382919 0.4618723844063366 1.0 1.0 3 P43490 1 |
| Gastric cancer network 2 0.3946934903324412 0.7067226804425667 0.4797388321564455 1.0 1.0 16 Q86UE4 1 |
| Network map of sarscov2 signaling pathway 0.3538371671011086 0.6985266935238922 0.484847870212469 1.0 1.0 26 Q15382,Q96AX1,Q9H269,Q08380,Q9P253,P14635,Q9UBR2,P06493,P42345,Q9UGN5 10 |
| Vitamin d receptor pathway 0.4111516164152927 0.6902977394588613 0.4900069691602926 1.0 1.0 12 P08183,P24941,P20020,Q92604,Q96KA5 5 |
| Id signaling pathway 0.7687245377624567 0.6476893976507911 0.5171858630320543 1.0 1.0 2 P24941 1 |
| 7oxoc and 7betahc pathways 0.4207090875190742 0.6268252233887153 0.5307738076325497 1.0 1.0 10 Q15125,P61916,Q9UBM7,O00154 4 |
| Joubert syndrome 0.3865094705732737 0.6203651458452795 0.5350174138422019 1.0 1.0 15 Q15382,Q13432,P42345,Q10713 4 |
| Cohesin complex cornelia de lange syndrome 0.3732817415545829 0.6202476831581716 0.5350947328134932 1.0 1.0 18 Q14674,P30154,Q8N3U4,Q16537,Q29RF7,Q7Z5K2,P06493,P30153 8 |
| Nephrotic syndrome 0.3946765263128853 0.616091144827316 0.5378343661324017 1.0 1.0 13 O75844,Q14108 2 |
| Praderwilli and angelman syndrome 0.4276654513559327 0.5666141182895628 0.5709763807827546 1.0 1.0 9 P11802,Q7L576,Q15154 3 |
| Thermogenesis 0.3371178604171283 0.5606089882629035 0.5750641227811102 1.0 1.0 26 Q15382,P42345,P23786,O43772 4 |
| Nocgmppkg mediated neuroprotection 0.4430268783068809 0.5549322303430826 0.5789410154609362 1.0 1.0 8 P30536 1 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3756169755940263 0.5528841144969936 0.5803427657545899 1.0 1.0 15 O15111,O95433,Q12959 3 |
| 3q29 copy number variation syndrome 0.3790343620179336 0.5471739494415231 0.5842592315386095 1.0 1.0 14 P02786,O95684 2 |
| Nuclear receptors metapathway 0.3233739303232077 0.5358857082457338 0.5920375423791893 1.0 1.0 46 Q15043,P08183,Q9H2J7,P23786,O00767,P27105,Q9HCL2,P09601,Q99735,Q15067 10 |
| Ovarian infertility 0.7298652460043928 0.5233965627074382 0.6006983156888421 1.0 1.0 2 P11802 1 |
| Vasopressinregulated water reabsorption 0.3588496861351081 0.5099276722442904 0.610102134380416 1.0 1.0 17 Q9UJW0,Q14203,Q13409,Q13561,Q15907,P52565 6 |
| Disruption of postsynaptic signaling by cnv 0.3979740229826384 0.5063206371752597 0.6126315778126461 1.0 1.0 10 Q7L576,Q06787,Q12959 3 |
| Hippo signaling regulation pathways 0.3781057212462798 0.5008078348448509 0.616506371099522 1.0 1.0 12 P10644,P42345 2 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.7195236602945829 0.4919791042367976 0.6227341154632415 1.0 1.0 2 P08195 1 |
| Irinotecan pathway 0.7160764650579776 0.4816793473091604 0.6300337495581838 1.0 1.0 2 O15118 1 |
| Mitochondrial immune response to sarscov2 0.4266875981161813 0.4784096418599062 0.6323586723957182 1.0 1.0 8 Q99623,Q7Z434,Q9BQ95,Q9H845,Q9Y276,Q9Y6M9,O94826 7 |
| S1p receptor signal transduction 0.424525860227601 0.4684705588476453 0.6394481201995792 1.0 1.0 8 Q13510 1 |
| Relationship between inflammation cox2 and egfr 0.5057934267497879 0.4617167471705281 0.6442844597495605 1.0 1.0 4 P31751 1 |
| Mitochondrial complex i assembly model oxphos system 0.3330869604139611 0.4582957084059804 0.646740006966529 1.0 1.0 23 Q9P0J0,O43676,Q96CU9 3 |
| Phosphoinositides metabolism 0.4191225405104168 0.4438364192076787 0.6571608555466062 1.0 1.0 8 Q9NTJ5,Q8TBX8,O00443 3 |
| Kennedy pathway from sphingolipids 0.4871057016248174 0.3949973997153777 0.692844806998208 1.0 1.0 4 O95470 1 |
| Interactions between loxl4 and oxidative stress pathway 0.665517241379316 0.3857717749567939 0.6996657006046392 1.0 1.0 3 Q8TAG9,Q16543 2 |
| Oxysterols derived from cholesterol 0.400458495360363 0.3612922859937846 0.7178809597170186 1.0 1.0 8 Q15125,Q9UBM7,O00154 3 |
| Neural crest cell migration during development 0.4086682480934627 0.3319668064183587 0.7399143236618388 1.0 1.0 6 P31751 1 |
| Angiogenesis 0.6385579937304139 0.3160373327042211 0.7519741718104158 1.0 1.0 3 P19174,Q16539 2 |
| Type ii diabetes mellitus 0.6385579937304139 0.3160373327042211 0.7519741718104158 1.0 1.0 3 O00330,P42345 2 |
| Arrhythmogenic right ventricular cardiomyopathy 0.3406824668143658 0.3141035735305359 0.7534423755073272 1.0 1.0 13 P50402 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3072687393058498 0.3111558855731641 0.7556821176998163 1.0 1.0 30 P48449,P54619,Q9NR31,O00767,Q8WTV0,Q9HCL2,Q14534,P04035,P55735,P42345,Q16850 11 |
| Cytosine methylation 0.4264191141991195 0.2897611659183134 0.7719989589606799 1.0 1.0 5 O75874 1 |
| Oxidative damage response 0.3952530092916214 0.2803980606527653 0.7791721247730408 1.0 1.0 6 Q16611 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.6219435736677187 0.2762026573731588 0.7823924163089147 1.0 1.0 3 O15111,P28482 2 |
| Nanoparticle triggered autophagic cell death 0.4165503436454684 0.256619853513869 0.7974722472458029 1.0 1.0 5 Q96GC9 1 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.416216977559068 0.2555249797543843 0.798317652756757 1.0 1.0 5 O00584 1 |
| Pathogenic escherichia coli infection 0.2978786050506612 0.2340977216200657 0.8149091146803316 1.0 1.0 24 P68371,P04350,P07437,Q16625,Q9BUF5 5 |
| Phase i biotransformations non p450 0.601017617975925 0.2297258959511605 0.8183047709441178 1.0 1.0 3 Q15165 1 |
| Thyroid hormones production and peripheral downstream signaling effects 0.3226415094339625 0.224437122820626 0.8224171875291708 1.0 1.0 13 Q15382,O60343,P28482,Q9UNY4,P62753,P62993,Q16539,Q7LBC6,O60341,Q02750,P35222,P42345 12 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.4027818264209493 0.2128066876170686 0.8314777472591941 1.0 1.0 5 O15111,P61201,P25490 3 |
| Supression of hmgb1 mediated inflammation by thbd 0.426293186228415 0.2062448381709248 0.8365996648601566 1.0 1.0 4 O15111 1 |
| Genes related to primary cilium development based on crispr 0.3063914461894711 0.1986581787370027 0.842530140435696 1.0 1.0 17 A0AVF1,O95684 2 |
| Neural crest cell migration in cancer 0.3717631821131184 0.1959033485385889 0.8446858162996178 1.0 1.0 7 P31751,Q13177 2 |
| Map3k1 role in promoting and blocking gonadal determination 0.5800103679807922 0.1874527941866321 0.8513056323503447 1.0 1.0 3 Q13464 1 |
| Vitamin b12 disorders 0.5791667852558808 0.1858499459255737 0.8525624355915122 1.0 1.0 3 Q99707 1 |
| Regucalcin in proximal tubule epithelial kidney cells 0.3657629066705025 0.1756362265879823 0.8605797400320878 1.0 1.0 7 Q16611 1 |
| Il18 signaling pathway 0.2639864502010495 0.1719796259220243 0.8634535464972293 1.0 1.0 58 Q86UL3,Q9NQX7,Q13011,P09601,Q9HC07,Q9UMR5,Q9Y6M7,O15111,P35613,Q9NZJ7 10 |
| Ppar signaling pathway 0.301253542444107 0.156155925214517 0.8759101170471928 1.0 1.0 16 O00767,P23786,O95864 3 |
| Angiopoietinlike protein 8 regulatory pathway 0.284648324139328 0.1529312062691075 0.8784525263231646 1.0 1.0 28 Q15382,P54619,O14654,O00443,O00767,P11166,Q16539,O75955,P41440,P31751,P42345 11 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2986004896950878 0.1433467692282395 0.8860163206954532 1.0 1.0 16 P50402,Q14739,P42167 3 |
| Retinoblastoma gene in cancer 0.2775981075796768 0.139988549021635 0.8886690378533137 1.0 1.0 48 O75419,P24941,P06400,P26583,P00374,P25205,Q16204,Q14566,Q9Y619,P06493,P14635,P33991,P35244,P11802,Q07864,P09455 16 |
| Ebsteinbarr virus lmp1 signaling 0.3709816503994491 0.1235342996348627 0.9016840151114796 1.0 1.0 5 O15111,P28482,P07900 3 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.337519623233918 0.1222122713746146 0.9027309081550968 1.0 1.0 8 P42224,Q7Z434,Q16539,Q13546,P19525,O15111,Q9Y6K9 7 |
| Rala downstream regulated genes 0.3688833124215885 0.1182690303263528 0.9058544953646586 1.0 1.0 5 Q8IYI6,P16989,P60953,Q96KP1 4 |
| Monoamine transport 0.3846120743516362 0.107971444394775 0.914018343832008 1.0 1.0 4 Q92692,O15127 2 |
| Ptf1a related regulatory pathway 0.5230335318082306 0.0878570567288372 0.9299902883305352 1.0 1.0 2 O00330 1 |
| Estrogen signaling pathway 0.3344838406024606 0.0842658694610155 0.9328450480816868 1.0 1.0 6 P28482,P05412,Q16539,Q9Y6K9,O15111 5 |
| Fatty acid transporters 0.3703355283787979 0.0808451689934004 0.935565085947446 1.0 1.0 4 P33121,O95573,Q6P1M0 3 |
| Mirna regulation of prostate cancer signaling pathways 0.3221350078492973 0.0755726025003467 0.93975913415067 1.0 1.0 8 P28482,P62993,Q02750,P35222,P36507,Q9Y6K9,P42345 7 |
| Small cell lung cancer 0.2797832835150998 0.0523625978388429 0.9582397758126376 1.0 1.0 15 P24941,O15111,P31751,P11802,Q16611 5 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.4722657474146167 0.0486241327820233 0.9612188375303206 1.0 1.0 2 P51532 1 |
| Amyotrophic lateral sclerosis als 0.2855135703452927 0.045987727864596 0.9633200313069414 1.0 1.0 11 P07196,Q9BUN8 2 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.2799072994308644 0.0457260973859928 0.9635285628546004 1.0 1.0 12 P13674,Q32P28 2 |
| Follicle stimulating hormone fsh signaling pathway 0.3186020140768012 0.0408255473283365 0.9674349725108564 1.0 1.0 7 Q15382,Q16539,P42345,P62753 4 |
| Sarscov2 b117 variant antagonises innate immune activation 0.448135380758404 0.0371770919820688 0.9703438039328024 1.0 1.0 2 O94826 1 |
| Cardiac hypertrophic response 0.2760116616479308 0.0328916472339054 0.9737609937351974 1.0 1.0 12 P31751,P42345 2 |
| Fluoropyrimidine activity 0.2807992923715705 0.0312516644862352 0.9750688377117238 1.0 1.0 11 Q99808,Q92820,P00374 3 |
| Endometrial cancer 0.2748901705775965 0.0303153313815149 0.9758155695182552 1.0 1.0 14 P31751 1 |
| Tyrobp causal network in microglia 0.3356898871247588 0.0288921816478065 0.9769505811616528 1.0 1.0 4 Q15758,P61916 2 |
| Gpr40 pathway 0.3832654340332233 0.0216739082010241 0.9827080771221156 1.0 1.0 2 P19174 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3216401849846493 0.0214431677201563 0.9828921386107932 1.0 1.0 5 P42345 1 |
| Myd88 distinct inputoutput pathway 0.3368849890316601 0.0182793550798002 0.9854159969754592 1.0 1.0 2 P61088 1 |
| Striated muscle contraction pathway 0.3206672676573177 0.0121586482348723 0.990299041313614 1.0 1.0 4 P08670 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.4209347563502402 0.0118251710511574 0.990565098477665 1.0 1.0 3 Q16611 1 |
|
|
